Companies supporting the fight against COVID-19

The COVID-19 pandemic is having a devastating personal and economic impact worldwide and there is an urgent need for governments, companies and individuals to play their part in helping to slow the spread, protect the vulnerable and minimise the human and economic toll.

Across our portfolios, there are a number of companies that are helping to play a crucial part, either by providing diagnostic tools, expanding their healthcare services, providing extra hand-washing and hygiene supplies or simply making sure we still have food available on our supermarket shelves. Below is a selection of the most notable examples:

  • DiaSorin – an Italian-listed multinational biotechnology company that has successfully launched a rapid response (60 minutes compared to the current 5-7 hours) COVID-19 diagnostic test and are working on an antibody test, expected soon.
  • Fisher & Paykel Healthcare – a New Zealand-listed manufacturer of products and systems for use in respiratory care, including breathing apparatus and masks. The company has ramped up their manufacturing output in order to meet the increasing global demand for their respiratory products that are directly involved in treating patients with COVID-19.
  • CSL – an Australian-listed company with dominant market position in blood plasma biotherapies used for treating rare diseases, supporting organ transplants, and developing vaccines and anti-venom serums. The company is working as part of an industry alliance to develop potential plasma-derived therapy for treating COVID-19. They are also donating proprietary technology to the University of Queensland’s pre-clinical development program.
  • Dr Lal Pathlabs – an Indian-listed blood testing and diagnostic laboratory chain which has been authorised for testing for COVID-19 in India.
  • Philips – a Dutch-listed conglomerate that is increasing the production of certain critical care products and solutions to help diagnose and treat patients, including hospital ventilators, vital sign monitors, diagnostic imaging and medical consumables.
  • Unilever – the UK and Dutch-listed consumer goods company is donating €100 million worth of soap, sanitiser, bleach and food to the COVID Action Platform of the World Economic Forum, as well as other product donations and handwashing education programmes at a national and local level. They are also offering€500 million of cash flow relief to support small and medium sized enterprises in their supply chain to help them with financial liquidity, and are extending credit to selected small-scale retail customers whose business rely on Unilever, to help them manage and protect jobs.

Of course there are many more examples of companies helping through their business-as-usual operations. These include Ain Holdings, the Japanese-listed franchisor of pharmacies and operator of drugstores, which provides access to consumer health and food products across Japan; Godrej Consumer, the Indian-listed consumer goods company, which sells health and hygiene supplies and also slashed the prices of their hand sanitisers; through to Neogen, the US-listed maker of food safety diagnostic tests, and animal health and hygiene products, including cleaners and disinfectants, for use in agricultural and food production settings. The EPA (United States Environmental Protection Agency) has approved four of their disinfectants to be used against Covid-19.

We trust these well stewarded companies will remain focused on the long-term and not exploit the obvious opportunity to put short-term profits ahead of patient and society welfare.

Important information

This document has been prepared for general information purposes only and is intended to provide a summary of the subject matter covered. It does not purport to be comprehensive or to give advice. The views expressed are the views of the writer at the time of issue and may change over time. This is not an offer document, and does not constitute an offer, invitation, investment recommendation or inducement to distribute or purchase securities, shares, units or other interests or to enter into an investment agreement. No person should rely on the content and/or act on the basis of any matter contained in this document.

This document is confidential and must not be copied, reproduced, circulated or transmitted, in whole or in part, and in any form or by any means without our prior written consent. The information contained within this document has been obtained from sources that we believe to be reliable and accurate at the time of issue but no representation or warranty, express or implied, is made as to the fairness, accuracy or completeness of the information. We do not accept any liability for any loss arising whether directly or indirectly from any use of this document.

References to “we” or “us” are references to Stewart Investors. Stewart Investors is a trading name of First Sentier Investors (UK) Funds Limited, First Sentier Investors International IM Limited and First Sentier Investors (Ireland) Limited. First Sentier Investors entities referred to in this document are part of First Sentier Investors, a member of MUFG, a global financial group. First Sentier Investors includes a number of entities in different jurisdictions. MUFG and its subsidiaries do not guarantee the performance of any investment or entity referred to in this document or the repayment of capital. Any investments referred to are not deposits or other liabilities of MUFG or its subsidiaries, and are subject to investment risk including loss of income and capital invested.

Reference to specific securities (if any) is included for the purpose of illustration only and should not be construed as a recommendation to buy or sell. Reference to the names of any company is merely to explain the investment strategy and should not be construed as investment advice or a recommendation to invest in any of those companies.

Hong Kong and Singapore

In Hong Kong, this document is issued by First Sentier Investors (Hong Kong) Limited and has not been reviewed by the Securities & Futures Commission in Hong Kong. In Singapore, this document is issued by First Sentier Investors (Singapore) whose company registration number is 196900420D. This advertisement or publication has not been reviewed by the Monetary Authority of Singapore. Stewart Investors is a business name of First Sentier Investors (Hong Kong) Limited. Stewart Investors (registration number 53310114W) is a business division of First Sentier Investors (Singapore).


In Australia, this document is issued by First Sentier Investors (Australia) IM Limited AFSL 289017 ABN 89 114 194 311 (FSI AIM). Stewart Investors is a trading name of FSI AIM.

United Kingdom

This document is not a financial promotion. In the United Kingdom, this document is issued by First Sentier Investors (UK) Funds Limited which is authorised and regulated in the UK by the Financial Conduct Authority (registration number 143359). Registered office: Finsbury Circus House, 15 Finsbury Circus, London, EC2M 7EB, number 2294743.

European Economic Area (“EEA”)

In the EEA, this document is issued by First Sentier Investors (Ireland) Limited which is authorised and regulated in Ireland by the Central Bank of Ireland (registered number C182306) in connection with the activity of receiving and transmitting orders. Registered office: 70 Sir John Rogerson’s Quay, Dublin 2, Ireland, number 629188.

Middle East

In certain jurisdictions the distribution of this material may be restricted. The recipient is required to inform themselves about any such restrictions and observe them. By having requested this document and by not deleting this email and attachment, you warrant and represent that you qualify under any applicable financial promotion rules that may be applicable to you to receive and consider this document, failing which you should return and delete this e-mail and all attachments pertaining thereto. In the Middle East, this material is communicated by First Sentier Investors (Singapore).


If in doubt, you are recommended to consult a party licensed by the Capital Markets Authority (“CMA”) pursuant to Law No. 7/2010 and the Executive Regulations to give you the appropriate advice. Neither this document nor any of the information contained herein is intended to and shall not lead to the conclusion of any contract whatsoever within Kuwait.

UAE - Dubai International Financial Centre (DIFC)

Within the DIFC this material is directed solely at Professional Clients as defined by the DFSA’s COB Rulebook.


By having requested this document and / or by not deleting this email and attachment, you warrant and represent that you qualify under the exemptions contained in Article 2 of the Emirates Securities and Commodities Authority Board Resolution No 37 of 2012, as amended by decision No 13 of 2012 (the “Mutual Fund Regulations”). By receiving this material you acknowledge and confirm that you fall within one or more of the exemptions contained in Article 2 of the Mutual Fund Regulations.

United States of America

In the United States, this document is issued by First Sentier Investors International IM Limited, as SEC registered investment adviser. Stewart Investors is the trading name of First Sentier Investors International IM Limited. This material is solely for the attention of institutional, professional, qualified or sophisticated investors and distributors who qualify as qualified purchasers under the Investment Company Act of 1940 (hereafter the “1940 Act”), as accredited investors under Rule 501 of SEC Regulation D under the US Securities Act of 1933 (“1933 Act), and as qualified eligible persons as defined under CFTC Regulation 4.7. It is not to be distributed to the general public, private customers or retail investors.

Other jurisdictions

In other jurisdictions where this document may lawfully be issued, this document is issued by First Sentier Investors International IM Limited which is authorised and regulated in the UK by the Financial Conduct Authority (registration number 122512). Registered office 23 St. Andrew Square, Edinburgh, EH2 1BB number SC079063.